KCT0002440尚未招募未知
Safety, effectiveness, and cost-effectiveness of an herbal medicine, Gongjin-dan, in subjects with chronic dizziness: a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group, clinical trial
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 79(Year)（—）
- 性别
- All
入选标准
- •1) Age between 20 and 79 years, of either sex
- •2) Dizziness originating from Ménière disease, psychogenic cause, or unknown cause
- •3) Recurring symptom of dizziness for more than 1 month
- •4) Dizziness Handicap Inventory (DHI) score = 24 at baseline
- •5) Liver-deficiency pattern/syndrome identified by Traditional Korean Medicine doctors
- •6) Willingness to provide written informed consent
排除标准
- •1) Dizziness attributable to vestibular disorders (e.g., benign paroxysmal positional vertigo, peripheral vestibulopathy, labyrinthitis, vestibular neuronitis, and others)
- •2) Dizziness attributable to central nervous system (CNS) disorders (e.g., cerebellar ataxia, stroke, demyelination, vertebrobasilar insufficiency, seizure, increased intracranial pressure, Parkinson's disease, migraines, and others)
- •3) Cervicogenic dizziness
- •4) Dizziness attributable to cardiovascular disorders (e.g., arrhythmia, heart valvular disease, anemia, orthostatic hypotension, coronary artery disease, and others)
- •5) Any active or uncontrolled disease that might cause dizziness (e.g., uncontrolled diabetes mellitus, hypertension, respiratory or endocrinological disorders, and others)
- •6) Dizziness attributable to medication side effects
- •7) Severe chronic or terminal diseases (malignant cancer, tuberculosis, and others)
- •8) Intake of other antivertiginous drugs that cannot be discontinued
- •9) Following physiotherapy, manual therapy (e.g., vestibular rehabilitation), and/or cognitive behavioral therapy for the treatment of dizziness
- •10) Aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), or creatinine > 3 × upper limit of normal range at baseline
- •11) Women of (suspected) pregnancy or breast-feeding
- •12) Allergic reactions to the study medications
- •13) Suspicion of alcohol and/or drug abuse
- •14 Enrollment in another clinical study presently or within 30 days prior to the initial administration of the study medications
- •15) Difficulty in reliably communicating with the investigators or likelihood of inability to follow instructions
- •16) Other reason for ineligibility of participation
研究者
相似试验
已完成
不适用
Clinical trial for safety, effectiveness, and economic evaluation of Ukgansangajinpibanha in subjects with autism spectrum disorderMental and behavioral disordersKCT0003007Kyung Hee University120
尚未招募
不适用
Effect of moxibustion therapy for aromataseinhibitor-induced arthralgia of postmenopausal breast cancer patientsKCT0003698Kyung Hee University46
尚未招募
不适用
Effectiveness, safety study of a herbal ointment, Jaungo, for radiation dermatitis of breast cancer patientsNeoplasmsKCT0003506Kyung Hee University80
已完成
不适用
Cost effectiveness, safety and efficiency of using a cannulatome versus a cannula for initial cannulation at endoscopic retro-grade cholangiopancreatography (ERCP) in suspected choledocolithiasis.ISRCTN54340540Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)50
未知
不适用
The investigation of the safety and efficiency of desk work using automatic wheel chair with assistance for standing in the person with a disability of lower extremityPerson with a disability of lower extremityJPRN-UMIN000023678Tottori University Hospital10